Medicine & Life Sciences
Dengue Virus
100%
Dengue
95%
DNA Vaccines
62%
Dengue Vaccines
57%
Indonesia
40%
Serogroup
37%
Vaccines
33%
Neutralizing Antibodies
31%
Viruses
26%
Severe Dengue
22%
Aotidae
18%
Antibodies
17%
Antibody Formation
17%
Ficusin
17%
Infections
16%
Haplorhini
14%
Viremia
13%
vaxfectin
12%
Viral RNA
11%
Macaca mulatta
11%
Animals
10%
Virus Diseases
10%
Muromegalovirus
9%
Flavivirus
9%
Proteins
9%
Dendritic Cells
9%
Disease Outbreaks
8%
Plasmids
8%
Polymerase Chain Reaction
8%
Serum
8%
Reverse Transcriptase Polymerase Chain Reaction
8%
Antigens
8%
Primates
7%
advax
7%
Clinical Trials, Phase I
7%
T-Lymphocytes
7%
Inactivated Vaccines
7%
Antibody-Dependent Enhancement
7%
Enzyme-Linked Immunosorbent Assay
7%
Volunteers
7%
1,2-diamino-1,2-N,N'-carbonyl-1,2-dideoxyglucose hydrate
7%
SARS Virus
6%
Immunoglobulin M
6%
Epidemics
6%
Chikungunya virus
6%
Genotype
6%
HIV-1
6%
Norovirus
6%
Salivary Glands
5%
Needles
5%
Agriculture & Biology
dengue
65%
Dengue virus
48%
recombinant vaccines
32%
vaccines
18%
dengue hemorrhagic fever
17%
immunogenicity
16%
neutralizing antibodies
14%
serotypes
12%
Indonesia
11%
Aotus (Cebidae)
9%
antibody formation
9%
viremia
9%
antibodies
8%
clinical trials
7%
psoralen
6%
viruses
6%
monkeys
6%
mice
6%
antigens
5%
reverse transcriptase polymerase chain reaction
5%
dosage
5%
animals
5%